Transcatheter aortic valve replacement (TAVR) is a relatively new technology in the field of medical science. It is a less invasive method of replacing heart valve without undergoing the conventional by-pass surgery. Aortic valve replacement typically requires open heart surgery, thus it disqualifies patients who are at high risk for the process or are too weak to undergo a surgery. As a result, the market of heart valve surgical procedures is witnessing a continuous decline as more and more patients requiring valve replacement are at risk for a surgical treatment. This shortcoming of the traditional surgical method has paved way for the popularity and adoption of TAVR. It was first commercially launched in Europe in 2007 and later in the United States. The market for TAVR is regarded to be promising with immense growth opportunities and unmet demand to cater to.

Rise in economic development, increasing old age population, growing obese population, and increase of aortic stenosis patients are some of the key drivers fueling the development of the global TAVR market. Growth of this market is largely dependent on macro indicators, like global GDP and global healthcare expenditure.

This report analyzes the development of “global TAVR market”, with special focus on the major markets like the United States and Europe. The major market trends and drivers that facilitate the growth of this market as well as the challenges it is facing are also analyzed in this report. The top players operating in the TAVR industry include Edward Lifesciences, Medtronic and St. Jude Medical and these companies have been profiled in the report highlighting their key financials and business strategies for growth and market expansion.

Table of Contents

1. Market Overview

2. TAVR Market Analysis
2.1 Global Market
TAVR Market Value: Actual & Forecast
Implants Sold: Actual & Forecast
2.2 Regional Markets
2.2.1 US Market
TAVR Market Value: Actual & Forecast
Implants Sold: Actual & Forecast
Patients at High Risk: Actual & Forecast
Implants by Patient Type: Actual & Forecast
Implants by Access Route: Actual & Forecast
2.2.2 Outside US Market
TAVR Market Value: Actual & Forecast
Patients at High Risk: Actual & Forecast
EU Implants Sold: Actual & Forecast
EU Implants by Patient Type: Actual & Forecast
EU Implants by Access Route: Actual & Forecast

3. Market Dynamics
3.1 Growth Drivers
3.1.1 Increasing Ageing Population
3.1.2 Rising Global Healthcare Expense
3.1.3 Increasing Obese Population
3.1.4 Global Economic Development
3.1.5 Increasing Prevalence of Inoperable Aortic Stenosis
3.2 Challenges
3.2.1 Regulatory Issues
3.2.2 Associated High Risk
3.2.3 High Cost of TAVR Devices
3.3 Key Trends
3.3.1 Favorable Reimbursement in Europe
3.3.2 Positive Outcomes from SAPIEN 3
3.3.3 TAVR for Low Risk Patients
3.3.4 Edwards Dominates TAVR Market

4. Competitive Landscape
4.1 Global Market
Product Comparison
Market Share
Implant Centers by Company
Implant Volume by Company
ASP Comparison
4.2 US
Market Share
Implant Centers by Company
Implant Volume by Company
ASP Comparison
4.3 Outside US
Market Share
Implant Centers by Company
Implant Volume by Company
ASP Comparison

5. Company Profiles
5.1 Edwards Lifesciences
5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategies
5.2 Medtronic
5.2.1 Business Overview
5.2.2 Financial Overview
5.2.3 Business Strategies
5.3 St. Jude Medical
5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Business Strategies

List of Tables

TAVR Market - Competitive Landscape
The US TAVR Market – Comparison (2014)
OUS TAVR Market – Total Implants by Company (2011-2014)

List of Charts

Global Transcatheter Aortic Valve Replacement (TAVR) Procedure
Global TAVR Market Value and Penetration (2011-2014)
Global TAVR Market Value Forecast (2015-2019)
Global TAVR Market- Implants Sold (2011-2014)
Global TAVR Market- Forecast of Implants to be Sold (2015-2019)
TAVR Market by Region (2014)
The US TAVR Market Value and Penetration (2011-2014)
The US TAVR Market Value Forecast (2015-2019)
The US TAVR Market- Implants Sold (2011-2014)
The US TAVR Patients at High Risk (2011-2014)
The US TAVR Patients at High Risk – Forecast (2015-2019)
US Implants Volume- By Patient Type (2014)
US Implants Volume Forecast- By Patient Type (2015-2018)
Breakdown of Implant Volumes in US- by Access Route (2014)
Forecasted Breakdown of Implant Volumes in US- by Access Route (2015-2018)
Japan/Europe/ROW TAVR Market Value and Penetration (2011-2014)
Japan/Europe/ROW TAVR Market Value Forecast (2015-2019)
OUS TAVR Market: Patients at High Risk (2011-2014)
OUS TAVR Market Forecast: Patients at High Risk (2015-2019)
EU Implants Sold (2011-2014)
EU Implants Sold Forecast (2015-2019)
EU Implants Volume-By Patient Type (2014)
EU Implants Volume Forecast - By Patient Type (2015-2019)
Total Implant Volumes in EU-By Access Route (2014)
EU Implants Volume Forecast - By Access Route (2015-2018)
Global Ageing Population Over 65 (2006-2014)
Global Health Care Expenditure per Capita (2009-2014E)
Global Obese Population (2009-2014)
Global GDP Growth (2010-2014)
Global TAVR Market Share by Revenue (2014)
Global TAVR Market – Implanting Centers by Company (2011–2015E)
Global TAVR Market – Total Implants by Company (2011-2015E)
Global TAVR Market – Average Selling Price of Implants by Company (2011–2015E)
The US TAVR Market Share by Revenue (2014)
Outside US TAVR Market Share by Revenue (2014)
OUS TAVR Market – Implanting Centers by Company (2011–2015E)
OUS TAVR Market – Average Selling Price of Implants by Company (2011–2014)
Edwards Lifesciences Revenue Share by Product Group (2014)
Edwards Life sciences Revenue Share by Geography (2014)
Edwards Lifesciences Revenue and Net Income (2010-2014)
Medtronic’s Revenue Share by Business Units (2014)
Medtronic’s Revenue and Net Income (2010-2014)
St. Jude Medical’s Revenue by Geography (2014)
St. Jude Medical’s Revenue by Device Type (2014)
St. Jude Medical’s Revenue (2010-2014)